Susan Jin

发表

Unresectable and Metastatic Melanoma of the Skin: Literature Review of Clinical Trials and Efficacy Endpoints Since 2000

R. Sridhara, P. Mishra-Kalyani, Susan Jin, 2019, Therapeutic innovation & regulatory science.

Re-Evaluating Eligibility Criteria for Oncology Clinical Trials: Analysis of Investigational New Drug Applications in 2015.

Richard Pazdur, Rajeshwari Sridhara, R. Pazdur, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

FDA Analysis of Survival Outcomes in Older Adults with Relapsed-Refractory Multiple Myeloma (RRMM) Treated with Novel Drug Regimens

R. Pazdur, R. Sridhara, A. Farrell, 2019, Blood.

FDA Accelerated Approval of Pembrolizumab for Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma.

P. Keegan, R. Pazdur, S. Lemery, 2020, The oncologist.